Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer
Open Access
- 28 April 2019
- Vol. 11 (5), 597
- https://doi.org/10.3390/cancers11050597
Abstract
Lung cancer is one of the leading causes of cancer-related death worldwide. Non-small cell lung cancer (NSCLC) causes around 80% to 90% of deaths. The lack of an early diagnosis and inefficiency in conventional therapies causes poor prognosis and overall survival of lung cancer patients. Recent progress in nanomedicine has encouraged the development of an alternative theranostics strategy using nanotechnology. The interesting physico-chemical properties in the nanoscale have generated immense advantages for nanoparticulate systems for the early detection and active delivery of drugs for a better theranostics strategy for lung cancer. This present review provides a detailed overview of the recent progress in the theranostics application of nanoparticles including liposomes, polymeric, metal and bio-nanoparticles. Further, we summarize the advantages and disadvantages of each approach considering the improvement for the lung cancer theranostics.Keywords
This publication has 114 references indexed in Scilit:
- Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancerAnnals Of Oncology, 2012
- Shape matters: effects of silver nanospheres and wires on human alveolar epithelial cellsParticle and Fibre Toxicology, 2011
- Peptides in cancer nanomedicine: Drug carriers, targeting ligands and protease substratesJournal of Controlled Release, 2011
- Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional PlatformsApplied Biochemistry and Biotechnology, 2011
- Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumorsJournal of Controlled Release, 2011
- Magnetic resonance and fluorescence imaging of doxorubicin-loaded nanoparticles using a novel in vivo modelNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Fluorescent Metal Nanoshell Probe to Detect Single miRNA in Lung Cancer CellAnalytical Chemistry, 2010
- Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protection in Mice against Diverse Respiratory VirusesPLOS ONE, 2009
- MRI-Visible Micellar Nanomedicine for Targeted Drug Delivery to Lung Cancer CellsMolecular Pharmaceutics, 2009
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences of the United States of America, 2006